First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent

Winnie Bergstedt, Pernille N Tingskov, Birgit Thierry-Carstensen, Søren T Hoff, Henrik Aggerbeck, Vibeke Thomsen, Peter Andersen, Åse Bengård Andersen

    36 Citationer (Scopus)

    Abstract

    Tuberculin is still the only available skin test reagent for the diagnosis of mycobacterial infection. The product has a remarkable sensitivity, but poor specificity. Previous studies, including two human phase I clinical trials, have indicated that rdESAT-6 has a potential as an improved skin test reagent. Animal studies have shown that the sensitivity may be increased by inclusion of the genetically related CFP-10 antigen in the preparation without loosing specificity.
    OriginalsprogEngelsk
    TidsskriftP L o S One
    Vol/bind5
    Udgave nummer6
    Sider (fra-til)e11277
    ISSN1932-6203
    DOI
    StatusUdgivet - 1 jan. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent'. Sammen danner de et unikt fingeraftryk.

    Citationsformater